Short interest in Outlook Therapeutics Inc (NASDAQ:OTLK) increased during the last reporting period, rising from 2.99M to 3.23M. This put 20.09% of the company's publicly available shares short.

Short interest for Outlook Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Outlook Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 312.73K shares traded per day, it would take 10.32 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.